These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19021293)

  • 41. Neprilysin deficiency-dependent impairment of cognitive functions in a mouse model of amyloidosis.
    Mohajeri MH; Wolfer DP
    Neurochem Res; 2009 Apr; 34(4):717-26. PubMed ID: 19199031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo.
    Hong CS; Goins WF; Goss JR; Burton EA; Glorioso JC
    Gene Ther; 2006 Jul; 13(14):1068-79. PubMed ID: 16541122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Gene therapy for Alzheimer' s disease].
    Iwata N; Ozawa K; Saido TC
    Nihon Rinsho; 2005 Mar; 63(3):394-400. PubMed ID: 15773336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation.
    Gallagher JJ; Minogue AM; Lynch MA
    Neurodegener Dis; 2013; 11(1):33-41. PubMed ID: 22627185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neprilysin protects neurons against Abeta peptide toxicity.
    El-Amouri SS; Zhu H; Yu J; Gage FH; Verma IM; Kindy MS
    Brain Res; 2007 Jun; 1152():191-200. PubMed ID: 17459354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolism of amyloid-beta peptide and Alzheimer's disease.
    Iwata N; Higuchi M; Saido TC
    Pharmacol Ther; 2005 Nov; 108(2):129-48. PubMed ID: 16112736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
    Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
    Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up-regulation of neprilysin mediates the protection of fructo-oligosaccharides against Alzheimer's disease.
    Wu S; Zhang J; Jiang C; Wang S; Que R; An L
    Food Funct; 2020 Jul; 11(7):6565-6572. PubMed ID: 32644062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating neprilysin clears brain amyloid.
    Liu Y; Studzinski C; Beckett T; Murphy MP; Klein RL; Hersh LB
    Mol Cell Neurosci; 2010 Oct; 45(2):101-7. PubMed ID: 20558294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling.
    Kim E; Kim H; Jedrychowski MP; Bakiasi G; Park J; Kruskop J; Choi Y; Kwak SS; Quinti L; Kim DY; Wrann CD; Spiegelman BM; Tanzi RE; Choi SH
    Neuron; 2023 Nov; 111(22):3619-3633.e8. PubMed ID: 37689059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alzheimer's disease, neuropeptides, neuropeptidase, and amyloid-beta peptide metabolism.
    Saito T; Takaki Y; Iwata N; Trojanowski J; Saido TC
    Sci Aging Knowledge Environ; 2003 Jan; 2003(3):PE1. PubMed ID: 12844556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons.
    Hama E; Shirotani K; Masumoto H; Sekine-Aizawa Y; Aizawa H; Saido TC
    J Biochem; 2001 Dec; 130(6):721-6. PubMed ID: 11726269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic regulation of brain Abeta by neprilysin.
    Iwata N; Tsubuki S; Takaki Y; Shirotani K; Lu B; Gerard NP; Gerard C; Hama E; Lee HJ; Saido TC
    Science; 2001 May; 292(5521):1550-2. PubMed ID: 11375493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form.
    Kanemitsu H; Tomiyama T; Mori H
    Neurosci Lett; 2003 Oct; 350(2):113-6. PubMed ID: 12972166
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2.
    Takamatsu K; Ikeda T; Haruta M; Matsumura K; Ogi Y; Nakagata N; Uchino M; Ando Y; Nishimura Y; Senju S
    Stem Cell Res; 2014 Nov; 13(3 Pt A):442-53. PubMed ID: 25460605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Amyloid-beta peptide metabolism and Alzheimer's disease].
    Iwata N; Saido TC
    Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):5-14. PubMed ID: 12843567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.